Single Technologies has developed an innovative approach to DNA sequencing through its proprietary 3-D Sequencing™ technology. This groundbreaking platform utilizes a multi-layered, cube-style infrastructure that significantly enhances the capacity for parallel DNA sequencing, moving beyond traditional flat methods. By enabling sequencing in three dimensions, the technology not only increases the number of DNA sequences that can be read simultaneously but also integrates spatial biology, allowing for a more comprehensive understanding of biological samples. The company's vision is to eliminate the bottlenecks in data generation, empowering scientists to tackle complex biological challenges with the aid of artificial intelligence.

In addition to its core sequencing technology, Single Technologies is committed to fostering collaboration with leading innovators and researchers to explore new applications in genomics and proteomics. The company emphasizes the importance of a multidisciplinary team, combining expertise from various scientific fields to drive advancements in sequencing technology. Their upcoming product, Theta, is poised to revolutionize DNA analysis with unmatched throughput and the ability to sequence directly within cells, unlocking intricate cellular insights. This focus on innovation and collaboration positions Single Technologies at the forefront of the life sciences, aiming to redefine research and technology in the field.

Sweden

SINGLE TECHNOLOGIES develops a new type of single molecule sensitive 3D sequencing system.

Single Technologies

Company Details